Alberta’s ambition to become Canada’s advanced ‘diagnostic hub’ is demonstrated through successful partnerships like the one between DynaLIFE and NanoSpeed, as part of the Alberta Diagnostics Ecosystem Platform for Translation (ADEPT) initiative being led through Alberta Innovates’ Health Innovation Platform Partnerships (HIPP) program.
“Our six-year partnership with DynaLIFE has transformed NanoSpeed enabling us to advance our diagnostic products from the R&D stage to commercialization,” comments Dr. Rajan Gupta, Founder of NanoSpeed. “DynaLIFE’s deep expertise in laboratory diagnostics, their accreditations and commitment to quality allowed us to develop tests that met the highest standards in Canada. We knew we wanted to partner with DynaLIFE not only for their untapped potential to provide the diagnostic industry services and the clinical setting we needed to progress towards commercialization, but also for the innovation culture DynaLIFE is renowned to bring with their talented and dedicated team.”
DynaLIFE and NanoSpeed’s partnership launched at the beginning of 2016 when they entered a multi-year research collaboration to accelerate the development of NanoSpeed’s technologies to provide critical new point of care tests to patients in Alberta. Beyond meeting this need at home, NanoSpeed also had a bigger vision to further leverage their existing distribution network to export these tests globally. By the close of 2016, NanoSpeed was a finalist in the category of Advanced Technology and Innovation by the Alberta Export Awards, the province’s most prestigious award paying tribute to the success and innovative approach by Alberta export companies for their Test4DTM product reaching global markets including Europe, China, India and the Philippines.
“I don’t only want to see Alberta keep pace with health innovation, but rather be the pace setter in health innovation,” comments Jason Pincock, CEO of DynaLIFE. “DynaLIFE’s agility and ability to provide our industry partners like NanoSpeed with patient samples, be a clinical trial facility for them serving as a third-party validation for their technology is another example of how we are supporting companies in our community to help diversify Alberta’s economy while enhancing patient heath.”
NanoSpeed recently celebrated the ground-breaking of its forthcoming new R&D and manufacturing facility in the Edmonton Research Park. Construction of their facility is anticipated to be completed by the end of 2021.
To learn more about NanoSpeed, click here.
To learn more about the Health Innovation Platform Partnership (HIPP) program, click here.
